THE MICHIGAN NEONATAL BIOBANK INC (EIN 262932780) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

CHRISTOPHER KRAUSE

Phone

3134831136

Tax Period

2024-10-01 to 2025-09-30

THE MICHIGAN NEONATAL BIOBANK INC, founded in 2009, is a small nonprofit in the Diseases & Disorders sector that reported $273K in total revenue in fiscal year 2024. Revenue grew 18% year-over-year, indicating healthy expansion. Expenses of $238K left a modest 13% surplus.

Mission

THE MICHIGAN NEONATAL BIOBANK IS A STORAGE AND MANAGEMENT FACILITY FOR THE MICHIGAN DEPARTMENT OF COMMUNITY HEALTH'S ARCHIVE OF DRIED BLOOD SPOTS. THE BIOBANK WILL PROVIDE RESEARCHERS ACCESS TO DRIED BLOOD SPOTS FOR RESEARCH INTO THE ORIGINS, PREVENTION AND CURES FOR DISEASES OF PUBLIC HEALTH CONCERN, WITH AN EMPHASIS ON PUBLIC HEALTH CONCERNS TO MICHIGAN CITIZENS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $181,018

Program Service Revenue $92,466

Investment Income $10

Other Revenue $0

TOTAL REVENUE $273,494

Expense Breakdown

Grants Paid $0

Salaries & Benefits $88,410

Fundraising Expenses $0

Program Expenses $225,132

Other Expenses $149,202

TOTAL EXPENSES $237,612

Year-over-Year Comparison

	2024	2023	Change
Revenue	$273,494	$230,836	+0.2%
Expenses	$237,612	$232,806	+0.0%
Net Income	$35,882	$-1,970	-19.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$85,608

Total Directors

$85,608

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BART WILLIAMS	DIRECTOR	1.00	Director	$0	$0	$0
SONIA HASSAN	DIRECTOR	1.00	Director	$0	$0	$0
EDWARD GOLDMAN	DIRECTOR	1.00	Director	$0	$0	$0
SANDIP SHAH	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER KRAUSE	EXECUTIVE DI	40.00	Officer Director	$65,090	$20,518	$85,608

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$273,494	$237,612	$235,126	$35,882
2024	$230,836	$232,806	$199,244	$-1,970
2023	$223,152	$314,317	$201,214	$-91,165
2022	$307,834	$261,869	$292,379	$45,965
2021	$243,222	$303,067	$246,414	$-59,845
2020	$298,813	$282,436	$306,259	$16,377
2019	$314,068	$242,494	$289,882	$71,574
2018	$246,756	$245,697	$218,308	$1,059

THE MICHIGAN NEONATAL BIOBANK INC